Evotec AG Receives Clinical Milestone as Part of Its Discovery Alliance With Boehringer Ingelheim Corporation
HAMBURG, Germany, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone in September triggering revenues of € 2.0 m to Evotec. The milestone was for the transition of an oncology molecule into Phase I clinical trials.
Help employers find you! Check out all the jobs and post your resume.